Botswana vs Pakistan: Cause of death, by non-communicable diseases, ages 0-4, female
Botswana
13.5%
in 2021
Pakistan
13.2%
in 2021
Botswana rank
134th
Pakistan rank
137th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Botswana
- Pakistan
How they compare
Botswana currently reports 13.5% against 13.2% in Pakistan, a difference of 0.3%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Botswana ahead.
Botswana ranks 134th and Pakistan ranks 137th of 185 countries.
Across the 3 decades both report, Botswana averaged higher in 2 and Pakistan in 1.
Head to head by decade
| Decade | Botswana | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 6.9% | 0.0% | Botswana |
| 2010s | 10.8% | 10.6% | 0.2% | Botswana |
| 2020s | 12.9% | 13.0% | 0.2% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Botswana or Pakistan?
- Botswana, at 13.5% against 13.2% in Pakistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Botswana and Pakistan?
- 0.3%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Pakistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Botswana and Pakistan rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Botswana ranks 134th and Pakistan ranks 137th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.